New Hampshire Medicaid and tirzepatide
Zepbound for weight loss: no. Still covered for moderate to severe sleep apnea with prior authorization, BMI 27 or higher. Mounjaro for weight loss: no; for type 2 diabetes New Hampshire Medicaid must cover it. Read from New Hampshire Department of Health and Human Services, Division of Medicaid Services documents Nov 6, 2026.
In 2025 New Hampshire Medicaid paid for 9,302 tirzepatide prescriptions (Zepbound, Mounjaro), 27% of its GLP-1 prescriptions and 34th of the 50 states and DC. It reimbursed $9.1 million before rebates, $983 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Zepbound | 6,455 | $6.4 million | $993 |
| Mounjaro | 2,847 | $2.7 million | $962 |
New Hampshire plans and prescribing rules
State of New Hampshire Health Benefit Plan. New Hampshire's Department of Administrative Services told the Governor and Council in August 2025 that the State Health Benefit Plan does not cover GLP-1 medications for weight loss.
Tirzepatide in the states around New Hampshire
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| New Hampshire | 17 | $69/moWellmedr | 9,302 | Medicaid Zepbound: No |
| Maine | 17 | $69/moWellmedr | 5,336 | Medicaid Zepbound: No |
| Massachusetts | 16 | $69/moWellmedr | 269,389 | Medicaid Zepbound: No |
| Vermont | 17 | $69/moWellmedr | 2,783 | Medicaid Zepbound: No |



